Welcome to CDC Stacks | Treatment options for latent tuberculosis infection - 41742 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Treatment options for latent tuberculosis infection
  • Published Date:
    August 2016
  • Language:
    English
Filetype[PDF - 1.30 MB]


Details:
  • Corporate Authors:
    National Center for HIV, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.
  • Series:
    TB elimination
  • Description:
    Treatment of latent tuberculosis (TB) infection (LTBI) is essential to controlling and eliminating

    TB in the United States, because it substantially reduces the risk that TB infection will progress to TB disease. The Centers for Disease Control and Prevention (CDC) and the United States Preventive Services Task Force (USPSTF) recommend testing populations that are at increased risk for TB infection. Once the diagnosis of LTBI has been made, health care providers must choose the most appropriate and effective treatment regimen, and make every effort to ensure those persons complete the entire course of treatment for LTBI.

    However, if exposed to and infected by a person with multidrug-resistant TB (MDR TB) or extensively drug-resistant TB (XDR TB), preventive treatment may not be an option.

    ltbitreatmentoptions_revised.pdf

  • Supporting Files:
    No Additional Files